식품의약품안전처가 유전자치료제로 승인받았던 코오롱생명과학의 인보사에 대한 허가를 취소한 가운데 식약처의 심의과정에 대한 의혹도 감사·수사해야 한다는 주장이 이어 나왔다.
While Ministry of Food and Drug Safety has revoked its permission for Kolon Life Sciences Inc.'s Invossa, which was approved as a gene therapy drug, it has also been called for an audit and investigation into suspicions over the ministry's deliberation process.